EUVIMEDEUVIMED entdecken
Open Access

Senolytic treatment for low back pain

Matthew Mannarino iD, Hosni Cherif iD, Saber Ghazizadeh iD, Oliver Wu Martinez, Kai Sheng iD, Elsa Cousineau, Seunghwan Lee iD, Magali Millecamps iD, Chan Gao, Alice Gilbert iD, Cedric Peirs iD, Reza Sharif-Naeini iD und 3 weitere

Science Advances · 14.03.2025 · 11 (11)

DOI: 10.1126/sciadv.adr1719 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 14.03.2025. Verfasst von Matthew Mannarino und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Orthopaedic Research Lab, McGill University, Montreal, QC, Canada. Hauptthemen laut MEDLINE: Low Back Pain, Senotherapeutics. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Senescent cells (SnCs) accumulate because of aging and external cellular stress throughout the body. They adopt a senescence-associated secretory phenotype (SASP) and release inflammatory and degenerative factors that actively contribute to age-related diseases, such as low back pain (LBP). The senolytics, o -vanillin and RG-7112, remove SnCs in human intervertebral discs (IVDs) and reduce SASP release, but it is unknown whether they can treat LBP. sparc −/− mice, with LBP, were treated orally with o -vanillin and RG-7112 as single or combination treatments. Treatment reduced LBP and SASP factor release and removed SnCs from the IVD and spinal cord. Treatment also lowered degeneration scores in the IVDs, improved vertebral bone quality, and reduced the expression of pain markers in the spinal cord. Together, our data suggest RG-7112 and o -vanillin as potential disease-modifying drugs for LBP and other painful disorders linked to cell senescence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Low Back PainSenotherapeuticsAnimalsMiceCellular SenescenceHumansIntervertebral DiscMice, KnockoutMaleDisease Models, AnimalSpinal Cord

Substanzen

Senotherapeutics

Autor:innen und Institutionen

  • Department of Surgery, Orthopaedic Research Lab, McGill University, Montreal, QC, Canada.
  • ABC-platform (Animal Behavioral Characterization) at the Alan Edwards Centre for Research on Pain, McGill University, Montreal, QC, Canada.
  • Alan Edwards Centre for Research on Pain (AECRP), McGill University, Montreal, QC, Canada.
  • Department of Surgery, McGill Scoliosis and Spine Group, McGill University, Montreal, QC, Canada.
  • Shriner's Hospital for Children, Montreal, QC, Canada.
  • Department of Anesthesiology, University of Minnesota, Minneapolis, MN, USA.

ORCID-Profile: Matthew Mannarino, Hosni Cherif, Saber Ghazizadeh, Kai Sheng, Seunghwan Lee, Magali Millecamps, Alice Gilbert, Cedric Peirs, Reza Sharif-Naeini, Laura S Stone, Lisbet Haglund

Zitieren

APA

Mannarino, M., Cherif, H., Ghazizadeh, S., Martinez, O. W., Sheng, K., Cousineau, E., Lee, S., Millecamps, M., Gao, C., Gilbert, A., Peirs, C., Sharif-Naeini, R., Ouellet, J. A., S Stone, L., & Haglund, L. (2025). Senolytic treatment for low back pain. Science Advances, 11(11). https://doi.org/10.1126/sciadv.adr1719

Vancouver

Mannarino M, Cherif H, Ghazizadeh S, Martinez OW, Sheng K, Cousineau E, et al. Senolytic treatment for low back pain. Science Advances. 2025;11(11). doi:10.1126/sciadv.adr1719

BibTeX
@article{Mannarino2025,
  author = {Mannarino, Matthew and Cherif, Hosni and Ghazizadeh, Saber and Martinez, Oliver Wu and Sheng, Kai and Cousineau, Elsa and Lee, Seunghwan and Millecamps, Magali and Gao, Chan and Gilbert, Alice and Peirs, Cedric and Sharif-Naeini, Reza and Ouellet, Jean A and S Stone, Laura and Haglund, Lisbet},
  title = {Senolytic treatment for low back pain},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {11},
  doi = {10.1126/sciadv.adr1719}
}
Kostenlos starten →